Laboratoire Physiopathologie et pharmacologie clinique de la douleur (LPPD)

Laboratory presentation

The LPPCD focuses on the mechanisms of hyperalgesia and allodynia in humans, that is, on neurological phenomena involving exacerbated pathological pain. This research theme represents a major public health focus up to 30% of the total population. Located on the CHU Ambroise Paré site in Boulogne Billancourt, the unit has a clinical research vocation and works closely with a large number of patients with acute or chronic pathological pain. In addition, the unit's clinician network, coming from different Paris hospitals, offers a real wealth of samples and patients to coordinate major clinical trials in the field.

The 20 latest publications

Title Authors Publication date Source
Diagnosing nociplastic pain in cancer survivors: a major step forward Nadine Attal 05/01/23 British Journal of Anaesthesia
Is fibromyalgia an immune-mediated disease? Anne Priscille Trouvin, Serge Perrot 05/01/23 Revue du Rhumatisme (Edition Francaise)
Diagnosis of neuropathic pain in polyneuropathy: should screening questionnaires be thrown out? Nadine Attal 05/01/23 Pain
Promoting inclusion, diversity and equity in pain science Didier Bouhassira 04/01/23 European Journal of Pain
Mechanisms of chronic pain in inflammatory rheumatism: the role of descending modulation Anne Priscille Trouvin, Terkia Medkour, Didier Bouhassira, Serge Perrot 03/01/23 Pain
Thermal grill illusion of pain in patients with chronic pain: a clinical marker of central sensitization? Frédéric Adam, Pauline Jouët, Jean Marc Sabaté, Serge Perrot, Claire Franchisseur, Nadine Attal, Didier Bouhassira 03/01/23 Pain
Promoting Inclusion, Diversity, and Equity in Pain Science Didier Bouhassira 02/17/23 Clinical Journal of Pain
Promoting Inclusion, Diversity, and Equity in Pain Science Didier Bouhassira 02/01/23 Journal of Pain
Promoting Inclusion, Diversity, and Equity in Pain Science Didier Bouhassira 02/01/23 Pain Medicine
Promoting inclusion, diversity, and equity in pain science Didier Bouhassira 02/01/23 Pain
Who really benefits from drug combinations and long titrations for pain? - Authors' reply Didier Bouhassira 01/21/23 The Lancet
Personalized treatment of neuropathic pain: Where are we now? Didier Bouhassira, Nadine Attal 01/01/23 European Journal of Pain
Patient Reported Outcome Measures in Chronic Neuropathic Pain Clinical Trials – A Systematic Literature Review Marie Péchard, Terkia Medkour, Didier Bouhassira 01/01/23 Journal of Pain
Neuropathy and pain after breast cancer treatment: A prospective observational study Nadine Attal, Didier Bouhassira 01/01/23 Scandinavian Journal of Pain
Promoting Inclusion, Diversity, and Equity in Pain Science Didier Bouhassira 01/01/23 Journal of Pain Research
Threats to the care of patients suffering from chronic pain in France: weakened chronic pain training and structures V. Martinez 01/01/23 Douleur et Analgesie
Pain and masochistic behaviour: The role of descending modulation Sophie Baudic, Frédérique Poindessous-Jazat, Didier Bouhassira 11/01/22 European Journal of Pain
Neurogenic inflammation as a novel treatment target for chronic pain syndromes Serge Perrot 10/01/22 Experimental Neurology
Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: A systematic review Anne Priscille Trouvin, Nadine Attal, Serge Perrot 10/01/22 Joint Bone Spine
Understanding chronic ocular surface pain: An unmet need for targeted drug therapy Nadine Attal 10/01/22 Ocular Surface

Number of publications of the laboratory by scientific field (2016-2021)

Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)